(100 days)
No
The summary describes standard soft contact lenses for vision correction and does not mention any AI or ML capabilities.
No
The intended use of the Clalen 54 and Clalen 58 contact lenses is for the correction of refractive error (myopia, hyperopia, astigmatism, presbyopia) in non-diseased eyes, not for treating a disease or therapeutic purpose.
No
Explanation: The provided text indicates that the device (contact lenses) is used for the "correction of refractive error" and is designed to sit on the eye, forming an optical surface. Its purpose is to correct vision, not to diagnose a medical condition.
No
The device description clearly indicates that the device is a physical contact lens made of specific materials (hioxifilcon D and hioxifilcon A) with defined physical properties. It is not a software program.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description and Intended Use: The text clearly describes the Clalen 54 and Clalen 58 lenses as soft contact lenses intended for the correction of refractive errors (myopia, hyperopia, astigmatism, presbyopia) in the eye. They are worn directly on the eye to improve vision.
- Lack of In Vitro Testing: There is no mention of the device being used to test samples taken from the body or to perform any diagnostic procedures outside of the body. The performance studies focus on toxicology, shelf life, physicochemical properties, and manufacturing verification, all related to the safety and function of the lens itself when worn on the eye.
Therefore, the Clalen 54 and Clalen 58 soft contact lenses are medical devices, but they do not fit the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Clalen 54 (hioxifilcon D) Spherical Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 54 (hioxifilcon D) Toric Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia and/or possesses refractive astigmatism not exceeding 5.00 diopters. The lens is available clear or tinted for visibility and handling.
The Clalen 54 (hioxifilcon D) Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by presbyopic persons requiring an add power ranging from +1.25D to +2.50D, and who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 54 (hioxifilcon D) Toric-Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia, possesses refractive astigmatism not exceeding 5.00 diopters. The lens may be worn by presbyopic persons requiring an add power ranging from +1.25D to +2.50D. The lens is available clear or tinted for visibility and handling.
Daily wear replacement schedules may vary from patient to patient and should be decided by eyecare practitioners in consultation with their patients.
Frequent/Planned Replacement Wear:
Eyecare practitioners may prescribe any of the above lenses for frequent/planned replacement wear, with cleaning disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be disinfected using a chemical disinfecting system.
Disposable Wear:
Eyecare practitioners may prescribe any of the above lenses for single use daily disposable wear. When Prescribed for daily disposable wear the lens is to be discarded after each removal.
The Clalen 58 (hioxifilcon A) Spherical Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 58 (hioxifilcon A) Toric Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia and/or possesses refractive astigmatism not exceeding 5.00 diopters. The lens is available clear or tinted for visibility and handling.
The Clalen 58 (hioxifilcon A) Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by presbyopic persons requiring an add power ranging from +1.25D to +2.50D, and who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 58 (hioxifilcon A)) Toric-Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia, possesses refractive astigmatism not exceeding 5.00 diopters. The lens may be worn by presbyopic persons requiring an add power ranging from +1.25D to +2.50D. The lens is available clear or tinted for visibility and handling.
Daily wear replacement schedules may vary from patient and should be decided by eyecare practitioners in consultation with their patients.
Frequent/Planned Replacement Wear:
Eyecare practitioners may prescribe any of the above lenses for frequent/planned replacement wear, with cleaning disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be disinfected using a chemical disinfecting system.
Disposable Wear:
Eyecare practitioners may prescribe any of the above lenses for single use daily disposable wear. When Prescribed for daily disposable wear the lens is to be discarded after each removal.
Product codes
LPL, MVN
Device Description
Clalen 54 (hioxifilcon D) Device Description:
The Clalen 54 Soft Contact Lenses are hemispherical shells with molded spherical base curves and molded front surfaces. The hydrophilic nature of this material allows the lens to become soft and pliable when immersed in an aqueous solution.
The non-ionic lens material (hioxifilcon D) is a co-polymer of 2-Hydroxyethylmethacrylate (2-HEMA) and 2,3- Dihydroxypropyl Methacrylate (Glycerol Methacrylate), cross-linked with ethylene glycol dimethacrylate (EGDMA). The co-polymer consists of 46% hioxifilcon D and 54% water by weight when immersed in saline solution. The lens is available with a blue visibility-handling tint, which includes [phthalocyaninato (2-)] copper and Reactive Blue 69. The hioxifilcon D name has been adopted by the U.S. Adopted Names Council (USAN).
A UV absorbing monomer-2-(Benzoyl-3-hydroxyphenoxy)ethyl acrylate-is incorporated in the Clalen 58 contact lens material to block UV radiation. The UV blocking characteristics of the lens are as follows:
-
95% in the UVB range of 280nm 315nm
-
70% in the UVA range of 316nm 380nm.
In the hydrated state, the lens conforms to the curvature of the eve covering the cornea and extending slightly beyond the limbus forming a colorless, transparent optical surface. The (hioxifilcon D) soft hydrophilic contact lens has a spherical back surface. The hydrophilic properties of the lens require that it be maintained in a fully hydrated state in a solution compatible with the eye. If the lens dries out, it will become hard and appear somewhat warped however, it will return to its proper configuration when completely rehydrated in the proper storage solution.
The hydrophilic characteristics allow aqueous solutions to enter the lens and in its fully hydrated state the lens is approximately 54% water by weight. The physical properties of the lens are:
Refractive Index: 1.404 (hydrated)
Light Transmission: greater than 96%
Water Content: 54 % ± 2%
Oxygen Permeability: 18.42 X 10-11 (cm²/sec) (ml O₂/ml x mm Hg @ 35 °C)
Clalen 58 (hioxifilcon A) Device Description:
The Clalen 58 Soft Contact Lenses are hemispherical shells with molded spherical base curves and molded front surfaces. The hydrophilic nature of this material allows the lens to become soft and pliable when immersed in an aqueous solution.
The non-ionic lens material (hioxifilcon A) is a co-polymer of 2-Hydroxyethylmethacrylate (2-HEMA) and 2,3- Dihydroxypropyl Methacrylate (Glycerol Methacrylate), cross-linked with ethylene glycol dimethacrylate (EGDMA). The co-polymer consists of 41% hioxifilcon A and 59% water by weight when immersed in saline solution. The lens is available with a blue visibility-handling tint, which includes Reactive Blue 69. The hioxifilcon A name has been adopted by the United States Adopted Names Council (USAN).
A UV absorbing monomer-2-(Benzoyl-3-hydroxyphenoxy)ethyl acrylate-is incorporated in the Clalen 58 contact lens material to block UV radiation. The UV blocking characteristics of the lens are as follows:
-
95% in the UVB range of 280nm 315nm
-
85% in the UVA range of 316nm 380mm.
In the hydrated state, the lens conforms to the curvature of the eye covering the cornea and extending slightly beyond the limbus forming a colorless, transparent optical surface. The (hioxifilcon A) soft hydrophilic contact lens has a spherical back surface. The hydrophilic properties of the lens require that it be maintained in a fully hydrated state in a solution compatible with the eye. If the lens dries out, it will become hard and appear somewhat warped however, it will return to its proper configuration when completely rehydrated in the proper storage solution.
The hydrophilic characteristics allow aqueous solutions to enter the lens and in its fully hydrated state the lens is approximately 59% water by weight. The physical properties of the lens are:
Refractive Index: 1.403 (hydrated)
Light Transmission: greater than 98%
Water Content: 59% ± 2%
Oxygen Permeability: 20.76 X 10-11 (cm²/sec) (ml O₂/ml x mm Hg @ 35°C), (revised Fatt method).
The Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) soft contact lenses will be manufactured in the sphere, toric, multifocal, and toric multifocal design configurations with the following features and properties:
Chord Diameter: 13.00 mm to 15.00 mm
Center Thickness: 0.080 mm to 0.580 mm
Base Curve: 8.0 mm to 9.8 mm
Power Range
- Sphere Power: -12.00D to +12.00D in 0.25D steps
- Cylinder Power (toric): -0.25D to -2.25D in 0.25D steps
- Cylinder Axis (toric): 10° to 180° in 10° steps
- Multifocal Power: +1.25 to +2.50 in 0.25D steps
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Eye / Cornea
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Eyecare practitioners
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Pre-Clinical Performance:
A series of preclinical testing was performed to demonstrate the safety and effectiveness of the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) finished contact lenses. The results support the claim that the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) Soft Contact Lenses are substantially equivalent to the currently marketed Hydrogel Vision Corporation hioxifilcon D (K051430) & hioxifilcon A (K992692) contact lenses. A summary of the results from the preclinical studies is presented below.
Toxicology:
All non-clinical toxicology tests were conducted in accordance with the GLP regulation.
In-Vitro Cytotoxicity: The test article meets the requirements of the Agarose Overlay Method in accordance with ISO 10993-5.
Systemic Toxicity: The lens material meets the requirements of the systemic injection test in accordance with ISO 10993-11 and is considered non-toxic.
Acute Ocular Irritation: Acute ocular irritation test was performed in accordance with ISO 10993-10 and produced no ocular irritation.
Shelf Life:
The data presented supports substantial equivalence of the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) finished contact lenses to the already marketed Hydrogel Vision Corporation hioxifilcon D (K051430) & hioxifilcon A (K992692) contact lenses, the predicate devices.
Physicochemical & Mechanical Properties:
Results of physicochemical and mechanical property testing demonstrate consistent material properties between the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) contact lenses and the predicate devices.
Manufacturing/Design Verification:
Results of manufacturing/design verification studies demonstrate the ability of Interojo, Inc. to manufacture, on a repeatable basis, the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) soft contact lens to a desired and predictable result within engineering tolerance and lens specifications.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K992692, K051430, K080794, K150293
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 886.5925 Soft (hydrophilic) contact lens.
(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized image of three human profiles facing right, stacked on top of each other. The profiles are black and have a flowing, abstract design. The profiles are surrounded by a circular border of text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA".
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
April 8, 2016
Interojo, Inc. % Mr. Bret Andre Official Correspondent Eyereg Consulting, Inc. 6119 Canter Ln. West Linn, OR 97068
Re: K153766
Trade/Device Name: Clalen 54 (hioxifilcon D) Soft (hydrophilic) Contact Lens For Daily Wear Clalen 58 (hioxifilcon A) Soft (hydrophilic) Contact Lens For Daily Wear Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (hydrophilic) Contact Lens Regulatory Class: Class II Product Code: LPL, MVN Dated: March 3, 2016 Received: March 4, 2016
Dear Mr. Andre:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Denise L. Hampton -S
for Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K153766
Device Name
Clalen 54 (hioxifilcon D) Soft (hydrophilic) Contact Lens for Daily Wear
Indications for Use (Describe)
The Clalen 54 (hioxifileon D) Spherical Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 54 (hioxifilcon D) Toric Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia and/or possesses refractive astigmatism not exceeding 5.00 diopters. The lens is available clear or tinted for visibility and handling.
The Clalen 54 (hioxifilcon D) Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by presbyopic persons requiring an add power ranging from +1.25D to +2.50D, and who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 54 (hioxifilcon D) Toric-Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia, possesses refractive astigmatism not exceeding 5.00 diopters. The lens may be worn by presbyopic persons requiring an add power ranging from +1.25D to +2.50D. The lens is available clear or tinted for visibility and handling.
Daily wear replacement schedules may vary from patient to patient and should be decided by eyecare practitioners in consultation with their patients.
Frequent/Planned Replacement Wear:
Eyecare practitioners may prescribe any of the above lenses for frequent/planned replacement wear, with cleaning disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be disinfected using a chemical disinfecting system.
Disposable Wear:
Eyecare practitioners may prescribe any of the above lenses for single use daily disposable wear. When Prescribed for daily disposable wear the lens is to be discarded after each removal.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
3
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
Indications for Use
510(k) Number (if known) K153766
Device Name
Clalen 58 (hioxifilcon A) Soft (hydrophilic) Contact Lens for Daily Wear
Indications for Use (Describe)
The Clalen 58 (hioxifilcon A) Spherical Soft Contact Lenses for daily wear are indicated for the correction of refractive r ror in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 58 (hioxifilcon A) Toric Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia and/or possesses refractive astigmatism not exceeding 5.00 diopters. The lens is available clear or tinted for visibility and handling.
The Clalen 58 (hioxifilcon A) Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive rerror in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by presbyonic persons requiring an add power ranging from +1.25D to +2.50D, and who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 58 (hioxifilcon A)) Toric-Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with myopia or hyperopia, possesses refractive astigmatism not exceeding 5.00 diopters. The lens may be worn by presbyopic persons requiring an add power ranging from +1.25D to +2.50D. The lens is available clear or tinted for visibility and handling.
Daily wear replacement schedules may vary from patient and should be decided by eyecare practitioners in consultation with their patients.
Frequent/Planned Replacement Wear:
Eyecare practitioners may prescribe any of the above lenses for frequent/planned replacement wear, with cleaning disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be disinfected using a chemical disinfecting system.
Disposable Wear:
Eyecare practitioners may prescribe any of the above lenses for single use daily disposable wear. When Prescribed for daily disposable wear the lens is to be discarded after each removal.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
5
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete time to review the collection. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
6
510 (k) SUMMARY OF SAFETY AND EFFECTIVENESS
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.
K153766 The assigned 510(k) number is:
Applicant information:
| Date Prepared: | December 28th, 2015 |
|---|---|
| Name: | |
| Address | Interojo, Inc. |
| 28& 25 Sandan-Ro 15 Beon-Gil | |
| Pyongtaek-City, Gyeonggido 459040 | |
| South Korea | |
| Contact Person: | Si-Chul Rho |
| President | |
| Phone number: | +82-2-780-1225 |
| Correspondent: | Bret J Andre |
| EyeReg Consulting, Inc. | |
| 6119 Canter Ln | |
| West Linn, OR 97068 | |
| United States | |
| (503) 372-5226 | |
| Device Information: | |
| Device Classification: | Class II |
| Classification Number: | LPL; MVN |
| Classification Name: | Soft (hydrophilic) Contact Lens (21 CFR 886.5925) |
| Trade Name: | Clalen 54 (hioxifilcon D) Soft (hydrophilic) Contact |
| Lens for Daily Wear | |
| Clalen 58 (hioxifilcon A) Soft (hydrophilic) Contact |
Lens for Daily Wear
7
Equivalent Devices:
The Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) Soft Contact Lenses are substantially equivalent to the following predicate device(s):
| Predicate device: |
|---|
| "Extreme H₂O 59% (hioxifilcon A) Soft Contact Lens" |
| Manufactured/distributed by Hydrogel Vision Corporation. |
| 510(k) number; K992692 |
| "Extreme H₂O 54% (hioxifilcon D) Soft Contact Lens" |
| Manufactured/distributed by Hydrogel Vision Corporation. |
| 510(k) number; K051430 |
| "I-55 (methafilcon A)" |
| Manufactured by Interojo, Inc. |
| Distributed by PolyVue Distribution, Inc. |
| 510(k) number; K080794 |
| ~ Reference Predicate |
| "EZvue UV (ocufilcon D)" |
| Manufactured by I-SEE VISION TECHNOLOGY INC. |
| 510(k) number: K150293 |
~ Reference Predicate
Clalen 54 (hioxifilcon D) Device Description:
The Clalen 54 Soft Contact Lenses are hemispherical shells with molded spherical base curves and molded front surfaces. The hydrophilic nature of this material allows the lens to become soft and pliable when immersed in an aqueous solution.
The non-ionic lens material (hioxifilcon D) is a co-polymer of 2-Hydroxyethylmethacrylate (2-HEMA) and 2,3- Dihydroxypropyl Methacrylate (Glycerol Methacrylate), cross-linked with ethylene glycol dimethacrylate (EGDMA). The co-polymer consists of 46% hioxifilcon D and 54% water by weight when immersed in saline solution. The lens is available with a blue visibility-handling tint, which includes [phthalocyaninato (2-)] copper and Reactive Blue 69. The hioxifilcon D name has been adopted by the U.S. Adopted Names Council (USAN).
A UV absorbing monomer-2-(Benzoyl-3-hydroxyphenoxy)ethyl acrylate-is incorporated in the Clalen 58 contact lens material to block UV radiation. The UV blocking characteristics of the lens are as follows:
- o >95% in the UVB range of 280nm 315nm
- o >70% in the UVA range of 316nm 380nm.
In the hydrated state, the lens conforms to the curvature of the eve covering the cornea and extending slightly beyond the limbus forming a colorless, transparent optical surface. The (hioxifilcon D) soft hydrophilic contact lens has a spherical back surface. The hydrophilic properties of the lens require that it be maintained in a fully hydrated state in a solution compatible with the eye. If the lens dries out, it will become hard and appear somewhat warped however, it will return to its proper configuration when completely rehydrated in the proper
8
storage solution.
The hydrophilic characteristics allow aqueous solutions to enter the lens and in its fully hydrated state the lens is approximately 54% water by weight. The physical properties of the lens are:
| Refractive Index | 1.404 (hydrated) |
|---|---|
| Light Transmission | greater than 96% |
| Water Content | 54 % ± 2% |
| Oxygen Permeability | 18.42 X 10-11 (cm2/sec) (ml O2/ml x mm Hg @ 35 °C) |
Clalen 58 (hioxifilcon A) Device Description:
The Clalen 58 Soft Contact Lenses are hemispherical shells with molded spherical base curves and molded front surfaces. The hydrophilic nature of this material allows the lens to become soft and pliable when immersed in an aqueous solution.
The non-ionic lens material (hioxifilcon A) is a co-polymer of 2-Hydroxyethylmethacrylate (2-HEMA) and 2,3- Dihydroxypropyl Methacrylate (Glycerol Methacrylate), cross-linked with ethylene glycol dimethacrylate (EGDMA). The co-polymer consists of 41% hioxifilcon A and 59% water by weight when immersed in saline solution. The lens is available with a blue visibility-handling tint, which includes Reactive Blue 69. The hioxifilcon A name has been adopted by the United States Adopted Names Council (USAN).
A UV absorbing monomer-2-(Benzoyl-3-hydroxyphenoxy)ethyl acrylate-is incorporated in the Clalen 58 contact lens material to block UV radiation. The UV blocking characteristics of the lens are as follows:
- o >95% in the UVB range of 280nm 315nm
- o >85% in the UVA range of 316nm 380mm.
In the hydrated state, the lens conforms to the curvature of the eye covering the cornea and extending slightly beyond the limbus forming a colorless, transparent optical surface. The (hioxifilcon A) soft hydrophilic contact lens has a spherical back surface. The hydrophilic properties of the lens require that it be maintained in a fully hydrated state in a solution compatible with the eye. If the lens dries out, it will become hard and appear somewhat warped however, it will return to its proper configuration when completely rehydrated in the proper storage solution.
The hydrophilic characteristics allow aqueous solutions to enter the lens and in its fully hydrated state the lens is approximately 59% water by weight. The physical properties of the lens are:
Refractive Index Light Transmission Water Content Oxygen Permeability
1.403 (hydrated)
greater than 98%
59% ± 2%
20.76 X 10-11 (cm²/sec) (ml O./ml x mm Hg @ 35℃),
(revised Fatt method).
Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) Specifications:
9
The Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) soft contact lenses will be manufactured in the sphere, toric, multifocal, and toric multifocal design configurations with the following features and properties:
| Chord Diameter: | 13.00 mm to 15.00 mm |
|---|---|
| Center Thickness: | 0.080 mm to 0.580 mm |
| Base Curve: | 8.0 mm to 9.8 mm |
| Power Range | |
| - Sphere Power: | -12.00D to +12.00D in 0.25D steps |
| - Cylinder Power (toric): | -0.25D to -2.25D in 0.25D steps |
| - Cylinder Axis (toric): | 10° to 180° in 10° steps |
| - Multifocal Power: | +1.25 to +2.50 in 0.25D steps |
Indications for Use:
The Clalen 54 (hioxifilcon D) Spherical Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 54 (hioxifilcon D) Toric Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia and/or possesses refractive astigmatism not exceeding 5.00 diopters. The lens is available clear or tinted for visibility and handling.
The Clalen 54 (hioxifilcon D) Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by presbyopic persons requiring an add power ranging from +1.25D to +2.50D, and who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 54 (hioxifilcon D) Toric-Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with nondiseased eyes with myopia or hyperopia, possesses refractive astigmatism not exceeding 5.00 diopters. The lens may be worn by presbyopic persons requiring an add power ranging from +1.25D to +2.50D. The lens is available clear or tinted for visibility and handling.
The Clalen 58 (hioxifilcon A) Spherical Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by persons who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 58 (hioxifilcon A) Toric Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia and/or possesses refractive astigmatism not exceeding 5.00 diopters. The lens is available clear or tinted for visibility and handling.
10
The Clalen 58 (hioxifilcon A) Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with non-diseased eyes with myopia or hyperopia. The lens may be worn by presbyopic persons requiring an add power ranging from +1.25D to +2.50D, and who exhibit refractive astigmatism of 0.75 diopters or less where the astigmatism does not interfere with visual acuity. The lens is available clear or tinted for visibility and handling.
The Clalen 58 (hioxifilcon A)) Toric-Multifocal Soft Contact Lenses for daily wear are indicated for the correction of refractive error in aphakic and not aphakic persons with nondiseased eyes with myopia or hyperopia, possesses refractive astigmatism not exceeding 5.00 diopters. The lens may be worn by presbyopic persons requiring an add power ranging from +1.25D to +2.50D. The lens is available clear or tinted for visibility and handling.
Daily wear replacement schedules may vary from patient and should be decided by eyecare practitioners in consultation with their patients.
Frequent/Planned Replacement Wear:
Eyecare practitioners may prescribe any of the above lenses for frequent/planned replacement wear, with cleaning disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be disinfected using a chemical disinfecting svstem.
Disposable Wear:
Eyecare practitioners may prescribe any of the above lenses for single use daily disposable wear. When Prescribed for daily disposable wear the lens is to be discarded after each removal.
Pre-Clinical Performance:
A series of preclinical testing was performed to demonstrate the safety and effectiveness of the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) finished contact lenses. The results support the claim that the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) Soft Contact Lenses are substantially equivalent to the currently marketed Hydrogel Vision Corporation hioxifilcon D (K051430) & hioxifilcon A (K992692) contact lenses. A summary of the results from the preclinical studies is presented below.
Toxicology:
All non-clinical toxicology tests were conducted in accordance with the GLP regulation.
In-Vitro Cytotoxicity: The test article meets the requirements of the Agarose Overlay Method in accordance with ISO 10993-5.
Systemic Toxicity: The lens material meets the requirements of the systemic injection test in accordance with ISO 10993-11 and is considered non-toxic.
Acute Ocular Irritation: Acute ocular irritation test was performed in accordance with ISO 10993-10 and produced no ocular irritation.
11
Shelf Life
The data presented supports substantial equivalence of the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) finished contact lenses to the already marketed Hydrogel Vision Corporation hioxifilcon D (K051430) & hioxifilcon A (K992692) contact lenses, the predicate devices.
Physicochemical & Mechanical Properties
Results of physicochemical and mechanical property testing demonstrate consistent material properties between the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) contact lenses and the predicate devices.
Manufacturing/Design Verification
Results of manufacturing/design verification studies demonstrate the ability of Interojo, Inc. to manufacture, on a repeatable basis, the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) soft contact lens to a desired and predictable result within engineering tolerance and lens specifications.
Substantial Equivalence:
The Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) soft contact lenses will be manufactured according to specified process controls and a cGMP quality assurance program currently in place as established by the I-55 reference predicate device (K080794).
The final packaging and sterilization of the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) soft contact lenses will be carried out in accordance with procedures specified for the I-55 reference predicate device (K080794).
The Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) soft contact lenses are substantially equivalent to the predicate device as depicted in the following table, and do not raise different questions of safety and effectiveness than the predicate device identified previously.
The following table depicts the pre-clinical characteristics of the Clalen 54 (hioxifilcon D) & Clalen 58 (hioxifilcon A) materials, as well as the predicate devices.
12
Substantial Equivalence Matrix
| | Interojo, Inc.
Clalen 54
(Subject Device) | Interojo, Inc.
Clalen 58
(Subject Device) | Hydrogel Vision
Corp.
Extreme H2O 54%
(Predicate Device) | Hydrogel Vision
Corp.
Extreme H2O 59%
(Predicate Device) |
|--------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Intended Use | Soft Contact Lenses for
daily wear are indicated
for the correction of
refractive error in aphakic
and not aphakic persons
with non-diseased eyes
with myopia or hyperopia
and/or are presbyopic. | Soft Contact Lenses for
daily wear are indicated
for the correction of
refractive error in aphakic
and not aphakic persons
with non-diseased eyes
with myopia or hyperopia
and/or are presbyopic. | Indicated for daily
wear for the correction
of refractive error in
aphakic and not
aphakic persons with
non-diseased eyes
with myopia or
hyperopia. | Indicated for daily
wear for the correction
of refractive error in
aphakic and not
aphakic persons with
non-diseased eyes with
myopia or hyperopia. |
| Functionality | The contact lenses act
as a refractive medium
that focus light rays
from near and distant
objects on the retina | The contact lenses act
as a refractive medium
that focus light rays
from near and distant
objects on the retina | The contact lenses
act as a refractive
medium that focus
light rays from near
and distant objects
on the retina | The contact lenses
act as a refractive
medium that focus
light rays from near
and distant objects
on the retina |
| Indications | Soft (hydrophilic) Contact
Lens (21 CFR 886.5925) | Soft (hydrophilic)
Contact Lens (21 CFR
886.5925) | Soft (hydrophilic)
Contact Lens (21 CFR
886.5925) | Soft (hydrophilic)
Contact Lens (21 CFR
886.5925) |
| Production Method | Fully molded | Fully molded | Fully molded | Fully molded |
| USAN name | hioxifilcon D | hioxifilcon A | hioxifilcon D | hioxifilcon A |
| Water Content (%) | 54±2% | 59±2% | 54±2% | 59±2% |
| Oxygen
Permeability | 18.42 x 10-11
(cm²/sec)(mlO₂)/(ml x mmHg
@ 35°C)) (revised Fatt
method) | 20.76 x 10-11
(cm²/sec)(mlO₂)/(ml x
mmHg @ 35°C)) (revised
Fatt method) | 14.86 x 10-11
(cm²/sec)(mlO₂)/(ml x
mmHg @ 35°C)) (revised
Fatt method) | 19.62 x 10-11
(cm²/sec)(mlO₂)/(ml x
mmHg @ 35°C)) (revised
Fatt method) |
| FDA Group | FDA Group 2
(>50% H₂O, non-ionic
polymer) | FDA Group 2
(>50% H₂O, non-ionic
polymer) | FDA Group 2
(>50% H₂O, non-
ionic polymer) | FDA Group 2
(>50% H₂O, non-
ionic polymer) |
| Refractive Index
(hydrated) | 1.404 | 1.403 | 1.409 | 1.392 |